Informa Plc (LON: INF), the International Exhibitions, Events, Business Intelligence and Academic Publishing Group, today announced the divestiture of the Life Sciences Media Brands Portfolio that was previously part of UBM plc, to MJH Associates, a leading US-based, independent full-service healthcare education, market research and multi-channel medical communications company, for a consideration of just over $100m.
This forms part of Informa’s PPM programme launched post the combination with UBM plc. This programme will increase the focus on businesses and Brands with strong market positions in core verticals, where the enlarged Informa portfolio is committed to future growth and scale.
The transaction does not include the CBI events business, which has been combined with the branded Life Sciences business within the Knowledge & Networking Division of Informa. The businesses being acquired by MJH are a portfolio of Life Science Media Brands that were previously reported within Other Marketing Services by UBM. These brands generate revenue largely through a mix of advertising and sponsorship, and cover three core vertical markets: Healthcare, (including brands such as Medical Economics, Practical Cardiology, Dermatology Times), Pharma (LC/GC, Pharmaceutical Technology, Spectroscopy, BioPharm International), and Animal Health (DVM360, Vetted, Firstline).
